These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1359717

  • 21. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 22. Treating peptic ulcer: an ongoing challenge.
    Cohen MH.
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract] [Full Text] [Related]

  • 23. Helicobacter pylori and peptic ulcer.
    Korman MG, Tytgat GN.
    Scand J Gastroenterol Suppl; 1995 Apr; 210():92-6. PubMed ID: 8578219
    [Abstract] [Full Text] [Related]

  • 24. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I, Herszényi L, Juhász M, Miheller P, Tulassay Z.
    Orv Hetil; 2006 Mar 12; 147(10):435-9. PubMed ID: 16573172
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M, Tsuda M, Okita K, Sugiyama T, Nakazawa T.
    Eur J Gastroenterol Hepatol; 1995 Aug 12; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [Abstract] [Full Text] [Related]

  • 26. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD, Fisher L, Elta GH, Barnett JL, Nostrant T, DelValle J, Hasler WL, Scheiman JM.
    Am J Gastroenterol; 1997 Sep 12; 92(9):1483-6. PubMed ID: 9317068
    [Abstract] [Full Text] [Related]

  • 27. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul 12; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 28. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H, Sánchez Anguiano LF, Quiñones E.
    Rev Gastroenterol Mex; 1998 Jul 12; 63(1):21-7. PubMed ID: 10068745
    [Abstract] [Full Text] [Related]

  • 29. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar 12; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 30. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan 15; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract] [Full Text] [Related]

  • 31. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB.
    Scand J Gastroenterol Suppl; 1995 Jan 15; 212():126-7. PubMed ID: 8578225
    [Abstract] [Full Text] [Related]

  • 32. Drugs for peptic ulcers.
    Treat Guidel Med Lett; 2004 Feb 15; 2(18):9-12. PubMed ID: 15529109
    [No Abstract] [Full Text] [Related]

  • 33. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P, Simon B.
    Fortschr Med; 1996 Dec 20; 114(35-36):497-9. PubMed ID: 9119351
    [Abstract] [Full Text] [Related]

  • 34. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN, Sung JJ, Yuen NW, Ng PW, Wong KC, Chung EC, Lim BH, Choi CH, Li TH, Ma HC, Kwok SP.
    Am J Gastroenterol; 1997 Mar 20; 92(3):438-41. PubMed ID: 9068464
    [Abstract] [Full Text] [Related]

  • 35. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr 20; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

  • 36. Suppression of Helicobacter pylori colonization with omeprazole.
    Fukuda Y.
    Scand J Gastroenterol Suppl; 1996 Apr 20; 214():54-5; discussion 57-60. PubMed ID: 8722408
    [Abstract] [Full Text] [Related]

  • 37. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan 15; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M, Bianchi Porro G.
    Drugs Aging; 1996 Oct 15; 9(4):251-61. PubMed ID: 8894523
    [Abstract] [Full Text] [Related]

  • 39. [Effect of the eradication of Helicobacter pylori on peptic ulcer healing].
    Harase I, Okuda J, Ida K.
    Nihon Rinsho; 1999 Jan 15; 57(1):162-6. PubMed ID: 10036956
    [Abstract] [Full Text] [Related]

  • 40. Short- and long-term management of peptic ulcer disease: current role of H2-antagonists.
    Brooks WS.
    Hepatogastroenterology; 1992 Feb 15; 39 Suppl 1():47-52. PubMed ID: 1349553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.